US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by PESG Research

News headline image
PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market
From PESG Research
Via Business Wire
Tickers IINN
News headline image
PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape
From PESG Research
Via Business Wire
Tickers NRSN
News headline image
PESG Report: Silexion Therapeutics’ Breakthrough Data Shows SIL204's impact on both Primary Tumors & Metastasis – Signaling a Potential Paradigm Shift in Cancer Treatment
From PESG Research
Via Business Wire
Tickers SLXN
News headline image
PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations
From PESG Research
Via Business Wire
Tickers IINN
News headline image
PESG Industry Update: Anticipation Rises as Silexion Therapeutics Approaches a Key Preclinical Data That Could Be Transformational
From PESG Research
Via Business Wire
Tickers SLXN
News headline image
PESG Releases Market Update: Silexion Therapeutics Advances KRAS-Targeting Therapies with New Collaboration As Industry Demand for Precision Oncology Solutions Rises
From PESG Research
Via Business Wire
Tickers SLXN
News headline image
PESG Research Report: Steakholder Foods Ventures into Alternative Assets as Treasury Strategy amidst Accelerating Commercialization
From PESG Research
Via Business Wire
Tickers STKH
News headline image
PESG Research Report: Steakholder Foods Delivering on Commercialization Promise; Strategic Partnerships and Revenue Streams Fuel Alternative Protein Expansion
From PESG Research
Via Business Wire
Tickers STKH
News headline image
PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update
From PESG Research
Via Business Wire
Tickers NVCT
News headline image
PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch
From PESG Research
Via Business Wire
Tickers NVCT
News headline image
PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers
From PESG Research
Via Business Wire
Tickers SLXN
News headline image
PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape
From PESG Research
Via Business Wire
News headline image
PESG Research Releases Industry Report on Steakholder Foods and the Cultured Meat Revolution
From PESG Research
Via Business Wire